Large‐scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels

Limitations of current diagnostic and prognostic tools for prostate cancer (PC) have led to over‐diagnosis and over‐treatment. Here, we investigate the biomarker potential of the SLC18A2 (VMAT2) gene for PC at three molecular levels. Thus, SLC18A2 promoter methylation was analyzed in 767 malignant a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Haldrup, Christa, Lynnerup, Anne-Sofie, Storebjerg, Tine Maj, Vang, Søren, Wild, Peter, Visakorpi, Tapio, Arsov, Christian, Schulz, Wolfgang A., Lindberg, Johan, Grönberg, Henrik, Egevad, Lars, Borre, Michael, Ørntoft, Torben Falck, Høyer, Søren, Sørensen, Karina Dalsgaard
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5423165/
https://ncbi.nlm.nih.gov/pubmed/26905753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2016.02.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados